Search | Page 16 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies

    ... Adequate hematopoietic recovery (ANC >500/mm^3 and platelet count >50,000/mm^3) Research participant or legal ...

    Clinical Trial last updated 06/06/2016 - 10:04am.

  2. Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

    ... (TPO) is the principal endogenous regulator of platelet production. In addition, TPO also has stimulatory effects on more ...

    Clinical Trial last updated 04/25/2016 - 2:47pm.

  3. Aplastic Anemia Clinical Trial at the NIH

    ... Food and Drug Administration (FDA) to treat low blood platelet counts in adults with chronic ITP (immune thrombocytopenic ...

    Research Review last updated 05/02/2016 - 9:26am.

  4. Bone Marrow Transplant

    ... to immunosuppressive therapy or those patients with low platelet counts while on  eculizumab should talk to their doctor about ...

    Topic section last updated 03/29/2016 - 7:27pm.

  5. Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 (DFCI 10-106)

    ... the study drugs or compounds of similar composition Platelet count <50,000/mm3, within 21 days of registration ANC <1,000 ...

    Clinical Trial last updated 05/23/2016 - 3:45pm.

  6. Treatments

    ... red blood cell , white blood cell or platelet counts. ...

    Topic section last updated 03/30/2016 - 3:13pm.

  7. Soliris

    ... does not help increase white blood cell count or platelet cell count. How You Take It Your doctor will give you an ...

    Page last updated 06/29/2015 - 9:07am.

  8. MDS Diagnostic Spectrum

    ... that incorporates prognostic information from karyotype, platelet count and transfusion status. JCO 2011;29(4): 392. ...

    Topic section last updated 03/11/2016 - 12:23am.

  9. Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

    ... ET ANY ONE of the following: Age ≥ 60 years Platelet count ≥ 1500 x 10 to 9/L Previous documented thrombosis, ... criteria as follows: Any ONE of the following: Platelet count ≥ 600 x 10 to 9/L after 3 months of at least 2 g/day of ...

    Clinical Trial last updated 04/29/2016 - 9:59am.

  10. Infections in myelodysplastic syndromes: a review

    ... requirements prior to starting azacytidine therapy and platelet counts < 20,000/μl to be significantly associated with occurrence ...

    Research Review last updated 05/02/2016 - 9:28am.